Global Cardiopulmonary Autotransfusion System Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Pharmaceutical

Cardiopulmonary Autotransfusion System Market Analysis Report provides market conditions and competition,which provide advantages for entry into new and established industries. This report focused on global and regional market, major manufacturers, as well as the segment market details on different classifications and applications.

“Cardiopulmonary autotransfusion system is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Scope of the Report:
This report focuses on the Cardiopulmonary Autotransfusion System in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa

Market Segment by Type, covers
Unwashed ATS
Washed ATS

Market Segment by Applications, can be divided into
Heart Surgery
Great Organ Transplant Surgery
Other Surgery

There are 13 Chapters to deeply display the global Cardiopulmonary Autotransfusion System market.

Chapter 1, to describe Cardiopulmonary Autotransfusion System Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cardiopulmonary Autotransfusion System, with sales, revenue, and price of Cardiopulmonary Autotransfusion System, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiopulmonary Autotransfusion System, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Cardiopulmonary Autotransfusion System market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Cardiopulmonary Autotransfusion System sales channel, distributors, traders, dealers, appendix and data source.

“Table of Contents

1 Market Overview 1
1.1 Cardiopulmonary Autotransfusion System Introduction 1
1.2 Market Analysis by Type 2
1.2.1 Unwashed ATS 4
1.2.2 Washed ATS 4
1.3 Market Analysis by Applications 5
1.3.1 Heart Surgery 6
1.3.2 Great Organ Transplant Surgery 6
1.4 Market Analysis by Regions 7
1.4.1 North America (USA, Canada and Mexico) 7
1.4.1.1 USA 7
1.4.1.2 Canada 8
1.4.1.3 Mexico 9
1.4.2 Europe (Germany, France, UK, Russia and Italy) 10
1.4.2.1 Germany 10
1.4.2.2 France 11
1.4.2.3 UK 11
1.4.2.4 Russia 12
1.4.2.5 Italy 13
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 14
1.4.3.1 China 14
1.4.3.2 Japan 15
1.4.3.3 Korea 16
1.4.3.4 India 17
1.4.3.5 Southeast Asia 18
1.4.4 Latin America, MEA 19
1.4.3.1 Brazil 19
1.4.3.2 Egypt 20
1.4.3.3 Saudi Arabia 21
1.4.3.4 South Africa 22
1.4.3.5 Nigeria 23
1.5 Market Dynamics 23
1.5.1 Market Opportunities 23
1.5.2 SWOT Analysis 24
1.5.3 Market Driving Force 24
2 Analysis of Cardiopulmonary Autotransfusion System Industry Key Manufacturers 26
2.1 Haemonetics 26
2.1.1 Company Profile 26
2.1.2 Product Information 27
2.1.2.1 Cell Saver? 5+ 27
2.1.2.2 Cell Saver? Elite? 28
2.1.3 Sales, Price, and Revenue 29
2.2 Medtronic 29
2.2.1 Company Profile 29
2.2.2 Product Information 30
2.2.3 Sales, Price, and Revenue 31
2.3 LivaNova 31
2.3.1 Company Profile 31
2.3.2 Product Information 33
2.3.2.1 XTRA 33
2.3.2.2 ORTHOFUSER 34
2.3.2.3 BRAT 2 35
2.3.2.4 ELECTA 36
2.3.3 Sales, Price, and Revenue 36
2.4 Fresenius Kabi 37
2.4.1 Company Profile 37
2.4.2 Product Information 38
2.4.3 Sales, Price, and Revenue 39
2.5 Terumo 40
2.5.1 Company Profile 40
2.5.2 Product Information 41
2.5.3 Sales, Price, and Revenue 41
2.6 Wandong Health Sources 42
2.6.1 Company Profile 42
2.6.2 Product Information 43
2.6.2.1 8200B Series 43
2.6.2.2 8200A Series 43
2.6.3 Sales, Price, and Revenue 44
3 Global Cardiopulmonary Autotransfusion Market Competition, by Manufacturer 44
3.1 Global Cardiopulmonary Autotransfusion Sales and Market Share by Manufacturer 44
3.2 Global Cardiopulmonary Autotransfusion Revenue and Market Share by Manufacturer 46
3.3 Market Concentration Rate 48
3.3.1 Top 3 Cardiopulmonary Autotransfusion Manufacturer Market Share 48
3.3.2 Top 6 Cardiopulmonary Autotransfusion Manufacturer Market Share 49
3.4 Market Competition Trend 50
4 Global Cardiopulmonary Autotransfusion Market Analysis by Regions 51
4.1 Global Cardiopulmonary Autotransfusion Sales, Revenue and Market Share by Regions 51
4.1.1 Global Cardiopulmonary Autotransfusion Sales by Regions (2011-2016) 52
4.1.2 Global Cardiopulmonary Autotransfusion Revenue by Regions (2011-2016) 53
4.2 North America Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 54
4.3 Europe Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 55
4.4 Asia-Pacific Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 56
4.5 Latin America, MEA Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 57
5 North America Cardiopulmonary Autotransfusion by Countries 58
5.1 North America Cardiopulmonary Autotransfusion Sales, Revenue and Market Share by Countries 58
5.1.1 North America Cardiopulmonary Autotransfusion Sales by Countries (2011-2016) 59
5.1.2 North America Cardiopulmonary Autotransfusion Revenue by Countries (2011-2016) 59
5.2 USA Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 60
5.3 Canada Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 61
5.4 Mexico Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 62
6 Europe Cardiopulmonary Autotransfusion by Countries 63
6.1 Europe Cardiopulmonary Autotransfusion Sales, Revenue and Market Share by Countries 63
6.1.1 Europe Cardiopulmonary Autotransfusion Sales by Countries (2011-2016) 64
6.1.2 Europe Cardiopulmonary Autotransfusion Revenue by Countries (2011-2016) 65
6.2 Germany Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 66
6.3 UK Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 67
6.4 France Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 68
6.5 Russia Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 69
6.6 Italy Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 70
7 Asia-Pacific Cardiopulmonary Autotransfusion by Countries 71
7.1 Asia-Pacific Cardiopulmonary Autotransfusion Sales, Revenue and Market Share by Countries 71
7.1.1 Asia-Pacific Cardiopulmonary Autotransfusion Sales by Countries (2011-2016) 72
7.1.2 Asia-Pacific Cardiopulmonary Autotransfusion Revenue by Countries (2011-2016) 73
7.2 China Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 74
7.3 Japan Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 75
7.4 Korea Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 76
7.5 India Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 77
7.6 Southeast Asia Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 78
8 Latin America, MEA Cardiopulmonary Autotransfusion by Countries 79
8.1 Latin America, MEA Cardiopulmonary Autotransfusion Sales, Revenue and Market Share by Countries 79
8.1.1 Latin America, MEA Cardiopulmonary Autotransfusion Sales by Countries (2011-2016) 80
8.1.2 Latin America, MEA Cardiopulmonary Autotransfusion Revenue by Countries (2011-2016) 81
8.2 Brazil Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 82
8.3 Saudi Arabia Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 83
8.4 Egypt Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 84
8.5 Nigeria Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 85
8.6 South Africa Cardiopulmonary Autotransfusion Sales and Growth (2011-2016) 86
9 Cardiopulmonary Autotransfusion Market Segment by Type 87
9.1 Global Cardiopulmonary Autotransfusion Sales, Revenue and Market Share by Type (2011-2016) 87
9.1.1 Global Cardiopulmonary Autotransfusion Sales and Market Share by Type (2011-2016) 87
9.1.2 Global Cardiopulmonary Autotransfusion Revenue and Market Share by Type (2011-2016) 87
9.2 Unwashed ATS Sales Growth and Price 88
9.2.1 Global Unwashed ATS Sales Growth (2011-2016) 88
9.2.2 Global Unwashed ATS Price (K USD/Unit) (2011-2016) 89
9.3 Washed ATS Sales Growth and Price 90
9.3.1 Global Washed ATS Sales Growth (2011-2016) 90
9.3.2 Global Washed ATS Price (K USD/Unit) (2011-2016) 91
10 Cardiopulmonary Autotransfusion Market Segment by Application 91
10.1 Global Cardiopulmonary Autotransfusion Sales Market Share by Application (2011-2016) 91
10.2 Heart Surgery Sales Growth (2011-2016) 92
10.3 Great Organ Transplant Surgery Sales Growth (2011-2016) 93
11 Cardiopulmonary Autotransfusion Market Forecast (2016-2021) 94
11.1 Global Cardiopulmonary Autotransfusion Sales, Revenue and Growth Rate (2016-2021) 94
11.2 Cardiopulmonary Autotransfusion Market Forecast by Regions (2016-2021) 95
11.3 Cardiopulmonary Autotransfusion Market Forecast by Type (2016-2021) 96
11.4 Cardiopulmonary Autotransfusion Market Forecast by Application (2016-2021) 96
12 Sales Channel, Distributors, Traders and Dealers 98
12.1 Sales Channel 98
12.2 Distributors, Traders and Dealers 98
13 Appendix 100
13.1 Methodology 100
13.2 Data Source 101



Inquiry Before Buying



Request For Sample